summary
Introduced
05/21/2020
05/21/2020
In Committee
05/21/2020
05/21/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
A bill to amend the Public Health Service Act to authorize the use of the Strategic National Stockpile to enhance medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies, and for other purposes. This bill requires the Department of Health and Human Services (HHS) to take specified actions, as part of its management of the Strategic National Stockpile, to establish and maintain domestic reserves of critical medical supplies. Specifically, HHS must (1) create incentives for manufacturers of medical supplies to increase emergency stocks and diversify geographic production; (2) purchase, lease, or enter into joint ventures with respect to facilities and equipment to produce medical supplies; and (3) work with distributors to refresh and replenish medical supplies. HHS must also submit a report to Congress concerning the details of any purchase, lease, or joint venture. The department's authority under the bill to make purchases, leases, or joint ventures for medical supplies terminates on September 30, 2023.
AI Summary
This bill, the Medical Supplies for Pandemics Act of 2020, amends the Public Health Service Act to authorize the Department of Health and Human Services (HHS) to take specific actions as part of managing the Strategic National Stockpile. HHS must create incentives for medical supply manufacturers to increase emergency stocks and diversify production locations, purchase or lease facilities and equipment for medical supply production, and work with distributors to refresh and replenish the domestic reserves of critical medical supplies, including personal protective equipment, ancillary medical supplies, and other supplies needed for administering drugs, vaccines, medical devices, and diagnostic tests. The bill also requires HHS to report to Congress on the details of any purchases, leases, or joint ventures entered into, and this authority expires on September 30, 2023. Additionally, the bill authorizes $500 million per fiscal year from 2020 to 2023 to carry out these supply chain flexibility and domestic reserve establishment activities.
Committee Categories
Health and Social Services
Sponsors (3)
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 05/21/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/senate-bill/3827/all-info |
| BillText | https://www.congress.gov/116/bills/s3827/BILLS-116s3827is.pdf |
| Bill | https://www.congress.gov/116/bills/s3827/BILLS-116s3827is.pdf.pdf |
Loading...